Work

The transformative breakthroughs in GLP-1 research recognized by the 2024 Lasker~DeBakey award

Year: 2024

Type: article

Abstract: Award has honored three pioneering scientists-Joel Habener, Svetlana Mojsov, and Lotte Bjerre Knudsenfor their groundbreaking contributions to the understanding and therapeutic application of glucagon-like peptide-1 (GLP-1) in the treatment of obesity.This recognition not only highlights their individual achievements but also underscores a significant shift in the landscape of metabolic disease treatment.The work of these researchers serves as a model for how basic science can translate into impactful clinical therapies, ultimately enhancing patient care and improving public health outcomes.

Source: Current Medicine

DOI: 10.1007/s44194-024-00041-w

Authors: Yu-Fei Zhou, Qi Li, Li-Guo Wang, Yu Lu, Yuji Wang, Jin-Kui Yang

Institutions: Beijing Tongren Hospital, Capital Medical University

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $1,570